Found 58 matching trials
A Randomized Secondary Adjuvant Treatment Intervention Study Comparing Trastuzumab-Deruxtecan to SOC Therapy in eBC Patients With Molecular Relapse PHASE3 Prospective, multi-center, randomized, open label comparative Phase III stu...
Show More Location
University Clinic Ulm
Learn More & Join Trial
Ribociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First Line PHASE3 This study is designed to evaluate the efficacy and safety of first-line tr...
Show More Location
Gemeinschaftspraxis fĂŒr HĂ€matologie und Onkologie
Learn More & Join Trial
Neoadjuvant Treatment of Breast Cancer N/A Observational investigation of participants who are given neoadjuvant treat...
Show More Location
National Institute of Oncolgy
Learn More & Join Trial
Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer PHASE3 AMBRE is a phase III study comparing two standard treatments as initial met...
Show More Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Learn More & Join Trial
Chemo-free in Older (â„65) Node-Positive ER+/HER2- Breast Cancer PHASE3 This study is a prospective, open-label, multicenter, randomized controlled...
Show More Location
Multiple Locations
Learn More & Join Trial
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer PHASE2 This study is a prospective, single-center, open-label, umbrella-shaped pha...
Show More Location
Cancer Hospital Affiliated to Fudan University
Learn More & Join Trial
Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study PHASE2 Women with recurrent or metastatic breast cancer who are hormone receptor p...
Show More Location
Clinical oncology department, Faculty of medicine, Ain Shams University
Learn More & Join Trial
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer PHASE2 This phase II trial studies how well a vaccine, STEMVAC, works in combinati...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients N/A What Comes After Fulvestrant? A Real World Multicenter Retrospective Study-...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer PHASE2 This phase II trial is studying how well giving hormone therapy together wi...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial